找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Gene, Drug, and Tissue Engineering; Glaucia C. Pereira Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive license

[复制链接]
查看: 21932|回复: 50
发表于 2025-3-21 19:39:48 | 显示全部楼层 |阅读模式
书目名称Gene, Drug, and Tissue Engineering
编辑Glaucia C. Pereira
视频video
概述Includes cutting-edge techniques.Provides step-by-step detail essential for reproducible results.Contains key implementation advice from the experts
丛书名称Methods in Molecular Biology
图书封面Titlebook: Gene, Drug, and Tissue Engineering;  Glaucia C. Pereira Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive license
描述This book combines discursive chapters that present the latest progress in molecular biology, drug discovery, organ-tissue engineering, and related fields, with a number of descriptive chapters on methods, protocols, and case studies. Structured into four parts, this volume walks the reader through the latest in cellular biology, with discussions on novel medicinal plant metabolites, nanotechnology in precision medicine, nucleic acid-based therapeutics and vaccines, genetic engineering, computational aid, bioinformatics, synthetic organs for transplantation, and organ-tissue engineering. Written for the highly successful .Methods in Molecular Biology. series, chapters include the kind of detail and expert implementation advice that ensures quality results in the lab. .Authoritative and informative, .Gene, Drug, and Tissue Engineering. serves as an ideal guide for undergraduate students, postgraduate researchers, and senior researchers working in biomedicine and its underlying technologies, stimulating both computational and experimental development and fostering the exchange of new ideas..
出版日期Book 2023
关键词Drug development; Bioengineering; Molecular genetics; SARS-CoV-2; Drug discovery; Precision medicine; Nucl
版次1
doihttps://doi.org/10.1007/978-1-0716-2716-7
isbn_softcover978-1-0716-2718-1
isbn_ebook978-1-0716-2716-7Series ISSN 1064-3745 Series E-ISSN 1940-6029
issn_series 1064-3745
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines
The information of publication is updating

书目名称Gene, Drug, and Tissue Engineering影响因子(影响力)




书目名称Gene, Drug, and Tissue Engineering影响因子(影响力)学科排名




书目名称Gene, Drug, and Tissue Engineering网络公开度




书目名称Gene, Drug, and Tissue Engineering网络公开度学科排名




书目名称Gene, Drug, and Tissue Engineering被引频次




书目名称Gene, Drug, and Tissue Engineering被引频次学科排名




书目名称Gene, Drug, and Tissue Engineering年度引用




书目名称Gene, Drug, and Tissue Engineering年度引用学科排名




书目名称Gene, Drug, and Tissue Engineering读者反馈




书目名称Gene, Drug, and Tissue Engineering读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:53:20 | 显示全部楼层
发表于 2025-3-22 00:27:14 | 显示全部楼层
Nanotechnology-Driven Delivery Systems in Inoculation Therapiesto stimulate immune responses, to both fight disease and create memory to trigger further responses to threat. A myriad of promising findings in cancer research and virology has been reported in the current literature. Nanosystems are demonstrating their capabilities as efficient carriers, improving
发表于 2025-3-22 07:34:25 | 显示全部楼层
发表于 2025-3-22 12:11:57 | 显示全部楼层
发表于 2025-3-22 15:52:02 | 显示全部楼层
Assessing the Challenges of Nanotechnology-Driven Targeted Therapies: Development of Magnetically Di by minimizing off-target interactions in healthy tissue. Both passive and active methods of targeting delivery have been proposed, often with particular emphasis on cancer treatment. Passive methods rely on the overexpression of a biomarker in diseased tissue that can then be used to target the the
发表于 2025-3-22 18:50:38 | 显示全部楼层
发表于 2025-3-22 23:18:22 | 显示全部楼层
发表于 2025-3-23 02:07:39 | 显示全部楼层
A Review of Stem Cell Technology Targeting Hepatocyte Growth as an Alternative to Organ Transplantatg unmatched demand of available organ donors and, as a consequence, the continuous growth of patients’ waiting lists, the development of new tissue engineering technologies is a relevant need. In this chapter, we will focus on the liver as a model organ to discuss contemporary tissue engineering str
发表于 2025-3-23 08:40:42 | 显示全部楼层
Novel Nanotechnology-Driven Prototypes for AI-Enriched Implanted Prosthetics Following Organ Failurely experiencing, since around December 2019. Innovation is key to respond rapidly and effectively to sanitary and health emergencies, when human lives are severely threatened. In this scenery, medical devices that can be rapidly launched in the market and manufactured at scale are crucial for saving
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 21:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表